Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pure Encapsulations

This article was originally published in The Tan Sheet

Executive Summary

Nutritional supplement company licensing Nutraceutix' patented Calcium D-Glucarate compound for a product expected to launch in early November. Sudbury, Mass.-based Pure Encapsulations, which markets its products solely to physicians and medical clinics, will sell the item in a 500 mg strength in 60- and 120-count sizes for about $39 and $66, respectively. Redmond, Wash.-based Neutraceutix also licenses a controlled delivery technology and molecular dispersion technology to MetRx

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090452

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel